Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide
Conditions: Meningioma Sponsors: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.
Conditions: COVID-19 Interventions: Drug: CD40.RBDv vaccin (SARS-Cov2 Vaccin) Sponsors: ANRS, Emerging Infectious Diseases; LinKinVax; Vaccine Research Institute (VRI), France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
Conditions: End Stage Renal Disease Interventions: Other: No systematic monitoring of symptoms; Other: Systematic monitoring of symptoms Sponsors: Central Hospital, Nancy, France; Agence de La Biom édecine; University of Bordeaux; Centre Hospitalier Régional Universitaire de Nancy; University Hospital, Bordeaux; University of Sydney; Centre Hospitalier Régional Universitaire de Tours; Association France REIN; Association AFIDTN (French Association of Dialysis, Transplant and Nephrology Nurs es); Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial
Conditions: Idiopathic Hypersomnia Interventions: Combination Product: - Melatonin - Active light ttherapy; Combination Product: - Placebo drug - Placebo light therapy Sponsors: University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit
Conditions: Colorectal Cancer Interventions: Diagnostic Test: Immunoscore Colon Test Sponsors: Assistance Publique - H ôpitaux de Paris; National Cancer Institute, France; Ministry of Health, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS Patients
Conditions: Amyotrophic Lateral Sclerosis ALS7 Interventions: Device: MI-E with PEP function activated during the pause; Device: MI-E without PEP function activated during the pause Sponsors: Groupe Hospitalier du Havre; French Physiotherapy Society / Soci été Français de Physiothérapie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood
Conditions: Endometriosis Sponsors: Institut National de la Sant é Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
Conditions: Low Risk Myelodysplastic Syndromes Interventions: Drug: RVU120 (SEL120) Sponsors: GCP-Service International West GmbH; Universit ätsklinikum Leipzig; Saint-Louis Hospital, Paris, France; University of Florence; University of Salamanca; Medical University of Warsaw; Ryvu Therapeutics SA; European Myelodysplastic Neoplasms Cooperative Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA)
Conditions: Ventilator Associated Pneumonia Interventions: Drug: Antibiotic Sponsors: French Society for Intensive Care Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Abivax Announces Update to Obefazimod Phase 2b Clinical Development Program in Moderately to Severely Active Crohn ’s Disease
PARIS, France, February 2, 2024, 8:30 a.m. CET– Abivax SA (Euronext Paris& Nasdaq: ABVX) (“Abivax” or the“Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 2, 2024 Category: Pharmaceuticals Source Type: clinical trials
Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.
Conditions: Patients With PH1 Treated With Lumasiran in France Interventions: Drug: Oxaluria evolution. Sponsors: Hospices Civils de Lyon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Early Detection of Triple Negative Breast Cancer Relapse
Conditions: Triple Negative Breast Cancer Interventions: Diagnostic Test: ctDNA monitoring; Diagnostic Test: 68Ga-FAPI-46-PET-CT Sponsors: Institut Curie; National Research Agency, France; Roche Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Assessment of Palatal Mucosal Thickness in Different Vertical Skeletal Pattern: a 3D Analysis
Conditions: Palatal Mucosa Thickness Interventions: Other: Measurement of palatal mucosa thickness on CBCT scans Sponsors: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Sociological Study of the Life Courses of Young TRANSgender Patients
Conditions: Transgenderism Interventions: Other: collection of biographical and sociological data Sponsors: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Male breAsT cAncer preDisposition Factor
Conditions: Breast Cancer Interventions: Other: Questionnaire completion Sponsors: Institut Claudius Regaud; Ligue contre le cancer, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
